1. Dallas TX, David W, Julie K. Staley behavioral neuroscience of drug addiction. Biosocieties. 2010; 39: 22-6.

2. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5Th ed. Washington, DC: APA. 2013.

3. Mokri A. Brief overview of the status of drug abuse in Iran. Archives of Iranian Medicine. 2002; 5: 184-90.

4. Paulus MP, Hozack NE, Zauscher BE, Frank L, Brown GG, Braff DL. Behavioral and functional neuroimaging evidence for prefrontal dysfunction in methamphetamine-dependent subjects. Neuropsychopharmacology. 2002; 26(1): 53-6. [DOI:10.1016/S0893-133X(01)00334-7]

5. Lyvers G, Leggio L, Abenavoli L, Gasbarrini G. Neurobiochemical and clinical aspects of craving in alcohol addiction: a review. Addict Behav. 2005; 30(6): 1209-24. [DOI:10.1016/j.addbeh.2004.12.011]

6. Czuchry M, Dansereau DF. Cognitive skills training: impact on drug abuse counseling and readiness for treatment. Am J Drug Alcohol Abuse. 2003; 29(1): 1-18. [DOI:10.1081/ADA-120018837]

7. Witkiewitz K, Marlatt A, Walker D. Ming – fullness- based relapse prevention for alcohol and substance use disorders. J Cogn Psychother. 2005; 19: 221-2. [DOI:10.1891/jcop.2005.19.3.211]

8. McLellan AG, Arndt IO, Metzger DS, Woody GE, O'Brien CP. The effects of psychosocial services in substance abuse treatment. JAMA. 1993; 269(15): 1953-9. [DOI:10.1001/jama.1993.03500150065028]

9. Layson-Wolf C, Goode JV, Small RE. Clinical use of methadone. J Pain Palliat Care Pharmacother. 2002; 16(1): 29-59. [DOI:10.1080/J354v16n01_04]

10. Connock M, Juarez-Garcia A, Jowett S, Frew E, Liu Z, Taylor RJ, et al. Methadone and buprenorphine for the management of opioid dependence: a systematic review and economic evaluation. Health Technol Assess. 2007; 11(9):1-171. [DOI:10.3310/hta11090]

11. Huizinga M, Dolan C, Van Der Molen M. Age-related change in executive function: developmental trends and a latent variable analysis. Neuropsychol. 2006; 44(11): 2017-36. [DOI:10.1016/j.neuropsychologia.2006.01.010]

12. Soyka M, Horak M, Dittert S, Kagerer S. Less driving impairment on buprenorphine than methadone in drug-dependent patients? J Neuropsychiatry Clin Neurosci. 2001; 13(4): 527-8. [DOI:10.1176/jnp.13.4.527]

13. Soyka M, Hock B, Kagerer S, Lehnert R, Limmer C, Kuefner H. Less impairment on one portion of a driving-relevant psychomotor battery in buprenorphine- maintained than in methadone-maintained patients. results of a randomized clinical trial. J Clin Psychopharmacol. 2005; 25(5): 490-3. [DOI:10.1097/01.jcp.0000178417.60426.60]

14. Gerra G, Borella F, Zaimovic A, Moi G, Bussandri M, Bubici C, et al. Buprenorphine versus methadone for opioid dependence: predictor variables for treatment outcome. Drug Alcohol Depend. 2004; 75(1): 37-45. [DOI:10.1016/j.drugalcdep.2003.11.017]

15. Barkley RA. Deficits in executive functioning scale (BDEFS). New York: Guilford Press; 2011.

16. Lyvers G, Leggio L, Abenavoli L, Gasbarrini G. Neurobiochemical and clinical aspects of craving in alcohol addiction: a review. Addictive Behaviors. 2005; 30(6): 1209-24. [DOI:10.1016/j.addbeh.2004.12.011]

17. Lezak MD. Neuropsychological assessment. 3rd ed. New York: Oxford University Press. 1995.

18. Bechara A, Dolan S, Denburg N, Hindes A, Anderson SW. Nathan PE. Decision-making deficits, linked to a dysfunctional ventromedial prefrontal cortex, revealed in alcohol a stimulant abuser. Neuropsychologia. 2001; 39(4): 376-89. [DOI:10.1016/S0028-3932(00)00136-6]

19. Darke S, Sims J, Mcdonald S, Wicks W. Cognitive impairment among methadone maintenance patients. Addiction. 2000; 95(5): 687-95. [DOI:10.1046/j.1360-0443.2000.9556874.x]

20. Giacomuzzi SM, Thill C, Riemer Y, Garber K, Ertl M. Buprenorphine-and methadone maintenance treatment: influence on aspects of cognitive and memory performance. Open Addict J. 2008; 1: 5-6. [DOI:10.2174/1874941000801010005]

21. Taube-Schiff M, Van Exan J, Tanaka R, Wnuk S, Hawa R, Sockalingam S. "Attachment style and emotional eating in bariatric surgery candidates: the mediating role of difficulties in emotion regulation". Eat Behav. 2015; 18: 36-40. [DOI:10.1016/j.eatbeh.2015.03.011]

22. Aldao A, Nolen-Hoeksema S, Schweizer S. Emotion-regulation strategies across psychopathology: a meta-analytic review. Clin Psychol Rev. 2010; 30(2): 217-37. [DOI:10.1016/j.cpr.2009.11.004]

23. Garnefski N, Teerds J, Kraaij V, Legerstee J, Van den Kommer T. Cognitive emotion regulation strategies and depressive symptoms: differences between males and females. Pers Individ Dif. 2004; 36(2): 267-76. [DOI:10.1016/S0191-8869(03)00083-7]

24. Barlow DH, Allen LB, Choate ML. Toward a unified treatment for emotional disorders. Behav Ther. 2004; 35(2): 205-230. [DOI:10.1016/S0005-7894(04)80036-4]

25. Savvas S, Somogyi A, White J. The effect of methadone on emotional reactivity. Addiction. 2012;107(2): 388-92. [DOI:10.1111/j.1360-0443.2011.03634.x]

26. Rolley E. Pharm D. Mary C. Eric S. Shahron W. Maxiline L. et al. A comparison of l evomethadyl acetate, buprenorphine, and methadone for opioid dependence. N Engl J Med. 2000; 324(2): 1290-4.

27. Yusefi F. The relationship of cognitive emotion regulation strategies with depression and anexiety in the middle students. Except Child. 2007; 4: 871-92.

28. Mashhadi A, Mirdoraghi F, Hosainzadeh-Maleki Z, Hasani J, Hamzeloo M. Factor structore, reliability and validity of persian version of barkeley deficits in executive functioning scale(BDEFS)- adult version. J Clin Psychol. 2015; 7(1): 51-62.

29. Rapeli P, Carola Fabritius C, Kalska H, Alho H. Memory function in opioid dependent patients treated with methadone or buprenorphine along with benzodiazepine: longitudinal change in comparison to healthy individuals. Subst Abuse Treat Prev Policy. 2009; 4: 6. doi:10.1186/1747-597X-4-6. [DOI:10.1186/1747-597X-4-6]

30. Rapeli P, Carola Fabritius C, Kalska H, Alho H. Cognitive functioning in opioid dependentpatients treated with buprenorphine, methadone,and other psychoactive medications: stability and correlates. BMC Clin Pharmacol. 2011; 11: 13. doi.org/10.1186/1472-6904-11-13. [DOI:10.1186/1472-6904-11-13]

31. Lundqvist T. Cognitive consequences of connobese use in comparison with abuse of stimulants and heroin with regard to attention, memory and executive functions. Pharmacol Biochem Behav. 2005; 81(2): 319-30. [DOI:10.1016/j.pbb.2005.02.017]

32. Von Geusau NA, Stalenhoef P, Huizinga M, Snel J, Ridderinkhof KR. Impaired executive function in male MDMA (''ecstasy'') users. Psychopharmacology (Berl). 2004; 175(3): 331-441. [DOI:10.1007/s00213-004-1832-8]

33. Hampshire A, Owen AM. Fractionating attentional control using eventrelated fmri. Cereb Cortex. 2006; 16(12): 1679-89. [DOI:10.1093/cercor/bhj116]

34. Rapeli P, Fabritius C, Alho H, Salaspuro M, Wahlbeck K, Kalska H. Methadone vs buprenorphine/naloxone during early opioid substitution treatment: a naturalistic comparison of cognitive performancerelative to healthy controls. BMC Clin Pharmacol. 2007; 7: 5. doi.org/10.1186/1472-6904-7-5. [DOI:10.1186/1472-6904-7-5]

35. Trindad DR, Unger Jb, Chou CO, Johnson A. The protective association of emotional intellegence with psychosocial smoking risking factors factor adolescent. personality and individual differences. Pers Individ Dif. 2004; 36(4): 945-54. [DOI:10.1016/S0191-8869(03)00163-6]

36. Trindad DR, Johnson CA. The association between emotion intelligence and early adolescent tobaco and alcohol use. Pers Individ Dif. 2002; 3(21): 95-105. [DOI:10.1016/S0191-8869(01)00008-3]

37. Wills TA, Vaccaro D, Mcnamara G. Novehty seeking, risk taking and related constructs as predictors of adolescent substance use: an application of cloninger s theory. J Subst Abuse. 1994; 6(1): 1-20 [DOI:10.1016/S0899-3289(94)90039-6]

38. Ipser JC1, Terburg D, Syal S, Phillips N, Solms M, Panksepp J, et al. Reduced fear-recognition sensitivity following acute buprenorphine administration in healthy volunteers. Psychoneuroendocrinology. 2013; 38(1): 166-70. [DOI:10.1016/j.psyneuen.2012.05.002]

39. Bershad AK, Seiden JA, de Wit H. Effects of buprenorphine on responses to social stimuli in healthy adults. Psychoneuroendocrinology. 2016; 63:43-9. [DOI:10.1016/j.psyneuen.2015.09.011]

40. Narimani M, Abasi M, Abolghasemi A, Ahadi B. Comparison of the effectiveness of acceptance / commitment with emotion regulation training on adjustment of students with dyscalculia. Middle Eastern Journal of Disability Studies. 2013; 4(2): 174-76.